Similarly, MM cells establish contact with bone marrow stromal cells via adhesion molecules such as VCAM1 and enhance osteoclast stimulating activity that can be reduced by Bortezomib and Lenalidomide69,70. This evidence concerns the gene VCAM1 and Miyoshi myopathy.